Scleroderma, Systemic: Clinical Trials

5 trials for Scleroderma, Systemic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Unknown 5

Follow Scleroderma, Systemic: new trials by email Literature Review of Scleroderma, Systemic trials Research Report on Scleroderma, Systemic

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Safety and Efficacy of Telitacicept in the Treatment of Systemic Sclerosis
Telitacicept - Systemic Sclerosis
Phase 4UnknownPeking University Third Hospital202024-06-082024-08-09
Efficacy and Safety of Pirfenidone in CTD-ILD
Pirfenidone, glucocorticoid and immunosuppressant - Pirfenidone, Connective Tissue Diseases
Phase 4UnknownQilu Hospital of Shandong University1202022-06-222022-11-30
Immunosuppressant Combined With Pirfenidone in CTD-ILD
Pirfenidone, DMARDs - Pirfenidone, Connective Tissue Diseases
Phase 4UnknownQilu Hospital of Shandong University2002019-08-162023-11-18
To Compare the Efficacy of Combination Therapy vs Monotherapy for Pulmonary Arterial Hypertension in Systemic Sclerosis
Sildenafil 20mg and Bosentan 62.5mg, Sildenafil 20mg and Placebo - Associated Pulmonary Arterial Hypertension
Phase 4UnknownPost Graduate Institute of Medical Education and Research, Chandigarh502016-12-012017-02-15
Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases
Anti-pandemic H1N1 influenza vaccine - Rheumatoid Arthritis, Spondyloarthritis
Phase 4UnknownUniversity of Sao Paulo50002010-04-012010-06-28

Narrower conditions

Arthritis, Rheumatoid (3)  ·  Connective Tissue Diseases (2)  ·  Lung Diseases, Interstitial (2)  ·  Myositis (2)  ·  Antiphospholipid Syndrome (1)  ·  Arthritis, Juvenile (1)  ·  Dermatomyositis (1)  ·  Influenza, Human (1)  ·  Lupus Erythematosus, Systemic (1)  ·  Rheumatic Diseases (1)  ·  Sjogren's Syndrome (1)  ·  Spondylarthritis (1)  ·  Systemic Vasculitis (1)

Broader conditions

Skin Diseases (5)  ·  Skin and Connective Tissue Diseases (5)  ·  Arthritis (3)  ·  Autoimmune Diseases (3)  ·  Connective Tissue Diseases (3)  ·  Immune System Diseases (3)  ·  Joint Diseases (3)  ·  Muscular Diseases (3)  ·  Musculoskeletal Diseases (3)  ·  Nervous System Diseases (3)  ·  Neuromuscular Diseases (3)  ·  Respiratory Tract Diseases (3)  ·  Lung Diseases (2)  ·  Rheumatic Diseases (2)  ·  Bone Diseases (1)

Interventions

pirfenidone (2)  ·  Antirheumatic Agents (1)  ·  Bosentan (1)  ·  Glucocorticoids (1)  ·  Immunosuppressive Agents (1)  ·  Sildenafil Citrate (1)  ·  telitacicept (1)

Sponsors

Qilu Hospital of Shandong University (2)  ·  Peking University Third Hospital (1)  ·  Post Graduate Institute of Medical Education and Research, Chandigarh (1)  ·  University of Sao Paulo (1)

Countries

China (3)  ·  Brazil (1)  ·  India (1)

Top investigators

Nandita Kakker, M.D (1)  ·  Yang Xiaoyun, Dr. (1)

Results publications

PMID 21540203, PMID 21859696, PMID 22089462, PMID 22298793, PMID 22908326, PMID 22931582, PMID 22949223, PMID 22992045, PMID 23123020, PMID 23525305, PMID 23818263, PMID 24961747, PMID 28968874